A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid.
about
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agentsValproic acid for the treatment of low-risk myelodysplastic syndromes: A case report and a review of the literature.Response to hydralazine-valproate in a patient with mycosis fungoidesThe gene signature in CCAAT-enhancer-binding protein α dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors.Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acidSpecific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemiaHistone deacetylase inhibitors: clinical implications for hematological malignancies.Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia.Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers.The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemiaTargeting of polo-like kinases and their cross talk with Aurora kinases--possible therapeutic strategies in human acute myeloid leukemia?An ATRActive future for differentiation therapy in AML.In Vitro Characterization of Valproic Acid, ATRA, and Cytarabine Used for Disease-Stabilization in Human Acute Myeloid Leukemia: Antiproliferative Effects of Drugs on Endothelial and Osteoblastic Cells and Altered Release of Angioregulatory MediatorSynergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.Cross-species functional genomic analysis identifies resistance genes of the histone deacetylase inhibitor valproic acid.Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cellsCombination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia--a report of five cases.Effect of valproic acid on the outcome of glioblastoma multiforme.Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.
P2860
Q24633763-E95D50B6-FFF2-49A9-88BC-16EE23D5292BQ33412339-DDFE1342-8DF1-4BFE-AF37-A5918C1F5FE7Q33743913-1110B940-BE56-4B95-BA3D-03BC84BC7BCDQ35026864-AD819524-7C7A-409F-9AA9-6B64103B5ACFQ35575464-9C6A7865-FCE8-407B-A633-FE3BA32470D2Q35664342-EF945C1A-E2CB-498E-8704-3BD19469CB34Q36001847-F8DED8B3-6DE6-4A17-A658-AC0F64870DAEQ36946725-C5F86DF4-9E48-41BD-97BB-A69BF5EBE6E7Q37114055-931FFA55-A943-4424-BC1B-244EC8D20623Q37153361-B46E57BD-8071-4F71-B4D1-6FD7B16C20D4Q37994256-2F2B0FE1-FA04-4BEB-B572-610C14DF6804Q38336112-5B966877-BE71-4A84-B5A2-51C4489BB5EBQ39023971-13B52FD0-0B0F-4BE9-99E4-8FB17F84BAA0Q39446764-A2F91465-BEE6-43D0-83ED-AE028DE3093CQ41147018-618E1094-D14D-428A-953E-2FA14F846405Q41625772-5023045D-12F8-464B-927C-BB291BDE13F1Q42878312-8CA647A8-3438-42C4-96F6-5A4C37BDA5D6Q45231801-82B57ACC-B731-4B5D-B6EB-272AF0A5449DQ47094576-EE5491C0-8227-4BCE-A002-AF40B5B3E150Q51102707-3769D8BC-8A29-4F7D-95C3-EEFB06D4291E
P2860
A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A subset of patients with high ...... e and all-trans retinoic acid.
@en
A subset of patients with high ...... e and all-trans retinoic acid.
@nl
type
label
A subset of patients with high ...... e and all-trans retinoic acid.
@en
A subset of patients with high ...... e and all-trans retinoic acid.
@nl
prefLabel
A subset of patients with high ...... e and all-trans retinoic acid.
@en
A subset of patients with high ...... e and all-trans retinoic acid.
@nl
P2093
P1433
P1476
A subset of patients with high ...... ne and all-trans retinoic acid
@en
P2093
Anita Ryningen
Camilla Stapnes
Matthias Corbascio
Oystein Bruserud
P304
P356
10.1016/J.LEUKRES.2008.10.005
P577
2008-11-12T00:00:00Z